HealthCor Partners Fund II, L.P. 4
Accession 0000908662-18-000165
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:26 PM ET
Size
18.8 KB
Accession
0000908662-18-000165
Insider Transaction Report
- Conversion
Series C Convertible Preferred Stock, par value $0.01
2017-12-19−20,487→ 26,200 totalFrom: 2017-12-19→ Common Stock (136,580 underlying) - Conversion
Common Stock, par value $0.01 per share
2017-12-19+136,580→ 174,472 total
- Conversion
Common Stock, par value $0.01 per share
2017-12-19+136,580→ 174,472 total - Conversion
Series C Convertible Preferred Stock, par value $0.01
2017-12-19−20,487→ 26,200 totalFrom: 2017-12-19→ Common Stock (136,580 underlying)
- Conversion
Series C Convertible Preferred Stock, par value $0.01
2017-12-19−20,487→ 26,200 totalFrom: 2017-12-19→ Common Stock (136,580 underlying) - Conversion
Common Stock, par value $0.01 per share
2017-12-19+136,580→ 174,472 total
- Conversion
Series C Convertible Preferred Stock, par value $0.01
2017-12-19−20,487→ 26,200 totalFrom: 2017-12-19→ Common Stock (136,580 underlying) - Conversion
Common Stock, par value $0.01 per share
2017-12-19+136,580→ 174,472 total
- Conversion
Series C Convertible Preferred Stock, par value $0.01
2017-12-19−20,487→ 26,200 totalFrom: 2017-12-19→ Common Stock (136,580 underlying) - Conversion
Common Stock, par value $0.01 per share
2017-12-19+136,580→ 174,472 total
- Conversion
Common Stock, par value $0.01 per share
2017-12-19+136,580→ 174,472 total - Conversion
Series C Convertible Preferred Stock, par value $0.01
2017-12-19−20,487→ 26,200 totalFrom: 2017-12-19→ Common Stock (136,580 underlying)
- Conversion
Common Stock, par value $0.01 per share
2017-12-19+136,580→ 174,472 total - Conversion
Series C Convertible Preferred Stock, par value $0.01
2017-12-19−20,487→ 26,200 totalFrom: 2017-12-19→ Common Stock (136,580 underlying)
- Conversion
Common Stock, par value $0.01 per share
2017-12-19+136,580→ 174,472 total - Conversion
Series C Convertible Preferred Stock, par value $0.01
2017-12-19−20,487→ 26,200 totalFrom: 2017-12-19→ Common Stock (136,580 underlying)
Footnotes (5)
- [F1]Share amounts and ratios reflect the 15-for-1 reverse stock split effected June 4, 2018.
- [F2]Automatic conversion of 20,487 shares of Series C Preferred Stock into shares of Common Stock at a conversion ratio of 1:6.6667.
- [F3]HealthCor Partners Fund II, L.P. ("HCPII Fund") is the direct beneficial owner of the securities reported herein. The shares held by HCPII Fund may be deemed to be beneficially owned by HealthCor Partners II, L.P. ("HCP2LP"), its general partner, and by HealthCor Partners GP, LLC ("HCPGP"), the general partner of HCP2LP. HealthCor Partners Management, L.P. ("HPMLP") serves as the investment manager to HCPII Fund, and HealthCor Partners Management GP, LLC ("HCPMGP") serves as the general partner of HPMLP. Jeffrey C. Lightcap, Arthur Cohen and Joseph Healey are managing members of HCPMGP and HCPGP. Each reporting person disclaims beneficial ownership of shares held by HCPII Fund except to the extent of any pecuniary interest therein.
- [F4]N/A
- [F5]Issued as merger consideration.
Documents
Issuer
ReShape Lifesciences Inc.
CIK 0001371217
Related Parties
1- filerCIK 0001538581
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:26 PM ET
- Size
- 18.8 KB